Virtu Financial’s Cellectar Biosciences, Inc. Series A Warrants CLRBZ Stock Holding History

Virtu Financial’s Portfolio CLRBZ Stock Details CLRBZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-21,755	Closed	-$8K	–	2412
2021 Q1	$8K	Buy	+21,755	New	+$5.92K	﹤0.01%	1528
2018 Q3	–	Sell	-11,892	Closed	-$2K	–	2435
2018 Q2	$2K	Buy	+11,892	New	+$4.23K	﹤0.01%	1927
2017 Q4	–	Sell	-15,596	Closed	-$10K	–	3243
2017 Q3	$10K	Buy	+15,596	New	+$9.13K	﹤0.01%	2412

Virtu Financial's CLRBZ Position: Q2 2021 in Review

Virtu Financial sold out of Cellectar Biosciences, Inc. Series A Warrants (CLRBZ) in Q2 2021, closing a stake of 21,755 shares — an estimated $8K sold.

Virtu Financial first reported a position in CLRBZ in Q3 2017 and held it in 3 quarters. The position peaked at $10K in Q3 2017. 0 funds tracked by Wall St. Rank hold CLRBZ as of Q2 2021.

Virtu Financial reported no remaining Cellectar Biosciences, Inc. Series A Warrants position as of Q2 2021 after selling out during the quarter.
Virtu Financial sold 21,755 Cellectar Biosciences, Inc. Series A Warrants shares in Q2 2021, an estimated $8K.
Virtu Financial first reported a position in Cellectar Biosciences, Inc. Series A Warrants in Q3 2017 and held it in 3 quarters.
Virtu Financial's Cellectar Biosciences, Inc. Series A Warrants position peaked at $10K in Q3 2017.
0 funds tracked by Wall St. Rank held Cellectar Biosciences, Inc. Series A Warrants as of Q2 2021.

Based on Virtu Financial's 13F filing for Q2 2021, filed 17 Sep 2021.